Crossmark

Design of the lentivirus-driven sustained LR12 delivery system for TREM-1 inhibition for palliating atherosclerosis

Published Online: 2022-01-10

Published Print: 2022-03

Authors

Thankam, Finosh G. https://orcid.org/0000-0001-7285-9808
Sanchez, David J.

Agrawal, Devendra K. https://orcid.org/0000-0001-5445-0013
Funding

Funding for this research was provided by:

National Institutes of Health (R01 HL144125, R01 HL147662)
License Information

Text and Data Mining valid from 2022-01-10

Version of Record valid from 2022-01-10
More Information

Article History

Received: 16 August 2021

Accepted: 29 November 2021

First Online: 10 January 2022

Declarations

:

: All authors have read the journal’s policy on disclosure of potential conflicts of interest. Authors DKA and DJS have received grants from the National Institutes of Health. Other authors have no relevant affiliations or financial or non-financial involvement with any organization or entity with financial or non-financial interest or conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. All authors declare that they have no conflict of interest.

: Not applicable.

Document is current